BioSpace News Archive

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced findings from a post hoc analysis of two long-term studies (KINECT™ 3 and KINECT™ 4) of INGREZZA® (valbenazine) capsules evaluating global tardive dyskinesia (TD) improvement and stability of psychiatric symptoms in adults with TD and schizophrenia or schizoaffective disorder.

Inhibikase Therapeutics, Inc. today reported financial results for the first quarter ended March 31, 2023 and highlighted recent developments.

RenovoRx, Inc. today announced financial results for the first quarter ended March 31, 2023.

CNS Pharmaceuticals, Inc. today reported its financial results for the quarter ended March 31, 2023 and provided a clinical update of its anti-cancer drug candidate currently in development for the treatment of primary and metastatic brain and CNS cancer.

Hillstream BioPharma, Inc. today announced the appointment of Kelly Anderson to its Board of Directors and committees, effective as of May 9, 2023.

Vaso Corporation (“Vaso”) (OTCQB:VASO) today reported its operating results for the three months ended March 31, 2023.

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, announces publication of an article in the peer-reviewed journal, Metabolism, which supports the mechanism of action of Cholesterol Efflux Mediator™ VAR 200 in development to treat kidney diseases.

Gracell Biotechnologies Inc. today announced that it will host a key opinion leader (KOL) webinar on May 22, 2023 at 9:00 am ET.

NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, today reported its financial and operational results for the first quarter ended March 31, 2023.

The Insight Partners published latest research report on “Global Artificial Intelligence in Healthcare Diagnosis Market Size Report, Share, Trends, Growth & Forecast to 2027 – COVID-19 Impact and Global Analysis – By Diagnostic Tool; Application; End User; and Service”, the global market is expected to reach USD 66,811.97 million by 2027 from USD 3,639.02 million in 2019.